In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Champions Oncology Inc.

www.championsoncology.com

Latest From Champions Oncology Inc.

WuXi Biologics Readies For Hong Kong IPO

As predicted by Scrip last July, WuXi AppTec has moved one step closer to spinning out its biologics unit through an IPO on the Hong Kong equity market, while its main business unit is also proceeding with plans for a China domestic relisting.

China Companies

Deals Shaping The Medical Industry, April 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March 2015.

BioPharmaceutical Medical Device

Mouse Avatars: Innovative Approach Holds Promise For Personalizing Cancer Treatment

Champions Oncology has developed TumorGraft, a novel predictive chemo-response technology that allows companies to simulate clinical trials, test anticancer drug regimens, and identify the regimens most likely to positively impact individual cancer tumors. For the clinical trial simulation capabilities alone, the technology has a market potential of $1.6 billion in the US, according to the company.

Medical Device Innovation

Execs On The Move, April 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
    • Pharmacogenetics-Pharmacogenomics
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Champions Biotechnology Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Champions Oncology Inc.
  • Senior Management
  • Joel Ackerman, CEO
    Ronnie Morris, MD, Pres.
    Angela M Davies, MD, CMO
    Keren Paz, PhD, CSO
    David Miller, VP, Fin.
  • Contact Info
  • Champions Oncology Inc.
    Phone: (201) 808-8400
    One University Plaza
    Ste. 307
    Hackensack, NJ 07601
    USA
UsernamePublicRestriction

Register